Disease Clusters?
Groups of diseases that share a large number of curated genes with each other, computed via label propagation over the shared-gene similarity graph. See also Shared-Gene Disease Pairs for pairwise comparisons.
← Back to all clusters
Cluster 470
6
Diseases
4
Unique genes
0.338
Avg. similarity score
Chronic mucocutaneous candidiasis
Most-connected disease (5 links)
Disease
Pinned (dragged)
Node size = connections within this cluster · edge thickness = similarity strength · hover an edge for its details ·
click a node to select it and show its pairs below (double-click or Ctrl/⌘-click opens the disease page) ·
drag a node to pin it in place · scroll/pinch to zoom.
Chronic mucocutaneous candidiasis
Candidiasis, familial, 2
Deep dermatophytosis
Immunodeficiency 103, susceptibility to fungal infections
Candidiasis, familial, 9
Mendelian susceptibility to mycobacterial disease
Member diseases (most connected first ‐ the cluster's core)
| Disease ⇵ | Connections in cluster ⇵ | Significant partners ⇵ | Curated genes ⇵ |
|---|---|---|---|
| Chronic mucocutaneous candidiasis | 5 | 5 | 3 |
| Candidiasis, familial, 2 | 3 | 3 | 1 |
| Deep dermatophytosis | 3 | 3 | 1 |
| Immunodeficiency 103, susceptibility to fungal infections | 3 | 3 | 1 |
| Candidiasis, familial, 9 | 1 | 1 | 1 |
| Mendelian susceptibility to mycobacterial disease | 1 | 1 | 2 |
Top shared genes (genes linked to 2+ member diseases)
| Gene ⇵ | Member diseases ⇵ | Linked diseases |
|---|---|---|
| CARD9 | 4 / 6 | Candidiasis, familial, 2, Chronic mucocutaneous candidiasis, Deep dermatophytosis, Immunodeficiency 103, susceptibility to fungal infections |
| IL17RC | 2 / 6 | Candidiasis, familial, 9, Chronic mucocutaneous candidiasis |
| IL23R | 2 / 6 | Chronic mucocutaneous candidiasis, Mendelian susceptibility to mycobacterial disease |
What do these columns mean?
- Connections in cluster
- How many other members this disease has a shared-gene link to (the node size in the network above). The most-connected diseases are the cluster's core.
- Significant partners
- How many of those links are statistically significant (FDR q < 0.05).
- Curated genes
- Distinct curated genes linked to that disease in GeDiPNet.
- Member diseases (Top shared genes)
- How many of this cluster's diseases are linked to the gene, out of the cluster's total. Genes shared by many members are the most direct explanation of why they group together.
- Overlap genes (x / y)
- x = genes shared between this cluster and the pathway/GO term; y = that pathway/GO term's total gene count. A higher x relative to y (and to the cluster's own size) means a tighter biological match.
- Cluster gene count
- Total distinct genes across every disease in this cluster -- the "n" used in the significance test below.
- Fold enrichment
- Observed overlap divided by the overlap expected by chance, given the cluster's gene count, the pathway/term's size and the gene universe tested. 5× means five times more shared genes than random. Tells strong hits apart when q-values are all vanishingly small.
- P-value / FDR q-value
- Is this pathway/GO term's overlap with the cluster more than chance? Upper-tail hypergeometric test, Benjamini-Hochberg corrected across every tested pathway/term (prefer the q-value -- it accounts for testing many at once).
- Shared genes (Pairs within this cluster)
- Number of curated genes the two diseases in that row have in common.
- Similarity score (Pairs within this cluster)
- Jaccard-based gene overlap between the two specific diseases in that row -- same metric as the main Shared-Gene Disease Pairs page.
Enriched Pathways (why this cluster is grouped, biologically)
| Pathway ⇵ | Source ⇵ | Overlap genes ⇵ | Fold enrichment ⇵ | P-value ⇵ | FDR q-value ⇵ |
|---|---|---|---|---|---|
| Cytokine-cytokine receptor interaction | KEGG | 3 / 298 | 30.2× | 5.94e-5 | 1.25e-3 ✓ sig. |
| Inflammatory bowel disease | KEGG | 2 / 66 | 91.0× | 1.77e-4 | 2.98e-3 ✓ sig. |
| JAK-STAT signaling pathway | KEGG | 2 / 168 | 35.7× | 1.15e-3 | 1.26e-2 ✓ sig. |
| Interleukin-17 signaling | Reactome | 1 / 8 | 375× | 2.66e-3 | 2.34e-2 ✓ sig. |
| Interleukin-23 signaling | Reactome | 1 / 9 | 334× | 2.99e-3 | 2.54e-2 ✓ sig. |
| Interleukin-12 signaling | Reactome | 1 / 10 | 300× | 3.33e-3 | 2.74e-2 ✓ sig. |
| Interleukin-35 Signalling | Reactome | 1 / 12 | 250× | 3.99e-3 | 3.12e-2 ✓ sig. |
| Pathways in cancer | KEGG | 2 / 533 | 11.3× | 1.11e-2 | 6.07e-2 |
| CLEC7A (Dectin-1) signaling | Reactome | 1 / 79 | 38.0× | 2.61e-2 | 9.99e-2 |
| Th1 and Th2 cell differentiation | KEGG | 1 / 93 | 32.3× | 3.06e-2 | 1.10e-1 |
| IL-17 signaling pathway | KEGG | 1 / 94 | 31.9× | 3.09e-2 | 1.10e-1 |
| C-type lectin receptor signaling pathway | KEGG | 1 / 105 | 28.6× | 3.45e-2 | 1.17e-1 |
| Interleukin-4 and Interleukin-13 signaling | Reactome | 1 / 108 | 27.8× | 3.55e-2 | 1.19e-1 |
| Th17 cell differentiation | KEGG | 1 / 109 | 27.5× | 3.58e-2 | 1.19e-1 |
| Alcoholic liver disease | KEGG | 1 / 144 | 20.9× | 4.71e-2 | 1.40e-1 |
Enriched GO Terms (Biological Process, a second line of biological evidence)
| GO term ⇵ | GO ID ⇵ | Overlap genes ⇵ | Fold enrichment ⇵ | P-value ⇵ | FDR q-value ⇵ |
|---|---|---|---|---|---|
| positive regulation of T-helper 17 type immune response | GO:2000318 | 2 / 13 | 719× | 2.68e-6 | 1.92e-4 ✓ sig. |
| positive regulation of granulocyte macrophage colony-stimulating factor production | GO:0032725 | 2 / 15 | 623× | 3.61e-6 | 2.43e-4 ✓ sig. |
| positive regulation of interleukin-17 production | GO:0032740 | 2 / 27 | 346× | 1.20e-5 | 6.28e-4 ✓ sig. |
| positive regulation of cytokine production involved in inflammatory response | GO:1900017 | 2 / 37 | 253× | 2.28e-5 | 1.02e-3 ✓ sig. |
| positive regulation of type II interferon production | GO:0032729 | 2 / 77 | 121× | 1.00e-4 | 3.10e-3 ✓ sig. |
| positive regulation of interleukin-6 production | GO:0032755 | 2 / 103 | 90.7× | 1.79e-4 | 4.70e-3 ✓ sig. |
| cytokine-mediated signaling pathway | GO:0019221 | 2 / 145 | 64.4× | 3.55e-4 | 7.57e-3 ✓ sig. |
| regulation of interleukin-2 production | GO:0032663 | 1 / 2 | 2,336× | 4.28e-4 | 8.53e-3 ✓ sig. |
| response to lipopolysaccharide | GO:0032496 | 2 / 161 | 58.0× | 4.38e-4 | 8.68e-3 ✓ sig. |
| prolactin signaling pathway | GO:0038161 | 1 / 4 | 1,168× | 8.56e-4 | 1.33e-2 ✓ sig. |
| granulocyte chemotaxis | GO:0071621 | 1 / 5 | 934× | 1.07e-3 | 1.51e-2 ✓ sig. |
| positive regulation of NK T cell activation | GO:0051135 | 1 / 5 | 934× | 1.07e-3 | 1.51e-2 ✓ sig. |
| response to fungus | GO:0009620 | 1 / 6 | 779× | 1.28e-3 | 1.67e-2 ✓ sig. |
| response to peptidoglycan | GO:0032494 | 1 / 6 | 779× | 1.28e-3 | 1.67e-2 ✓ sig. |
| interleukin-23-mediated signaling pathway | GO:0038155 | 1 / 6 | 779× | 1.28e-3 | 1.67e-2 ✓ sig. |
Pairs within this cluster, by significance
| Disease A ⇵ | Disease B ⇵ | Similarity score ⇵ | Shared genes ⇵ | P-value ⇵ | FDR q-value ⇵ |
|---|---|---|---|---|---|
| Candidiasis, familial, 2 | Deep dermatophytosis | 0.500 | 1 | 6.46e-5 | 1.98e-4 ✓ sig. |
| Candidiasis, familial, 2 | Immunodeficiency 103, susceptibility to fungal infections | 0.500 | 1 | 6.46e-5 | 1.98e-4 ✓ sig. |
| Deep dermatophytosis | Immunodeficiency 103, susceptibility to fungal infections | 0.500 | 1 | 6.46e-5 | 1.98e-4 ✓ sig. |
| Candidiasis, familial, 2 | Chronic mucocutaneous candidiasis | 0.250 | 1 | 1.94e-4 | 4.41e-4 ✓ sig. |
| Candidiasis, familial, 9 | Chronic mucocutaneous candidiasis | 0.250 | 1 | 1.94e-4 | 4.41e-4 ✓ sig. |
| Chronic mucocutaneous candidiasis | Deep dermatophytosis | 0.250 | 1 | 1.94e-4 | 4.41e-4 ✓ sig. |
| Chronic mucocutaneous candidiasis | Immunodeficiency 103, susceptibility to fungal infections | 0.250 | 1 | 1.94e-4 | 4.41e-4 ✓ sig. |
| Chronic mucocutaneous candidiasis | Mendelian susceptibility to mycobacterial disease | 0.200 | 1 | 3.87e-4 | 7.33e-4 ✓ sig. |